Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

;Total;Units;P.A.;Higher Education;PNPI;
Units that perform R+D in Biotechnology;1.332;1.133;120;67;12;
%Units according to biotechnology used: Genetic code;41;33;88;87;33;
%Units according to biotechnology used: Functional units;48;41;89;91;50;
%Units according to biotechnology used: Cellular and tissue culturing and engineering;31;24;74;82;50;
%Units according to biotechnology used: Bioprocesses;53;50;61;93;42;
%Units according to biotechnology used: Sub-cellular organisms;14;6;56;72;33;
%Units according to biotechnology used: Bio-computing;31;24;69;85;8;
%Units according to biotechnology used: Nanobiotechnology;19;13;50;70;8;
%Units according to biotechnology used: Other;14;14;8;18;8;
Units in which biotechnology activities are:  Main and/or exclusive;647;603;33;5;6;
Units in which biotechnology activities are: A secondary line of business;252;173;39;38;2;
Units in which biotechnology activities are: A tool necessary for production;433;357;48;24;4;
%Units by field(s) of ultimate application of biotechnology use: Human health;51;45;78;91;58;
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;20;18;15;67;8;
%Units by field(s) of ultimate application of biotechnology use: Food products;32;31;20;79;8;
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;24;22;19;73;25;
%Units by field(s) of ultimate application of biotechnology use: Environment;17;14;22;72;17;
%Units by field(s) of ultimate application of biotechnology use: Industry;15;12;12;67;8;
Personnel in R&D in biotechnology (no. of persons);40.018;11.510;13.944;14.415;149;
Personnel in R&D in biotechnology (no. of persons): Researchers;26.603;6.202;8.687;11.634;80;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;13.415;5.308;5.257;2.781;69;
Personnel in R&D in biotechnology (no. of persons): women;22.240;6.389;8.590;7.165;96;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;13.936;3.304;5.040;5.545;47;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;8.305;3.086;3.550;1.620;49;
Personnel in R&D in biotechnology (FTE);27.550,6;8.236,9;10.492,6;8.726,3;94,8;
Personnel in R&D in biotechnology (FTE): Researchers;17.572,9;4.596,1;6.124,4;6.798,1;54,3;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;9.977,7;3.640,8;4.368,2;1.928,2;40,5;
Personnel in R&D in biotechnology (FTE): women;15.792,1;4.698,5;6.519,9;4.509;64,7;
Personnel in R&D in biotechnology (FTE): (women) Researchers;9.524,4;2.512,5;3.603,3;3.374,3;34,3;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;6.267,7;2.186;2.916,6;1.134,7;30,4;
Internal expenditure on R&D (thousands of euros);1.783.011;769.431;596.928;411.163;5.489;
1) By nature of the expense: Current expenses;1.673.710;719.715;567.086;381.526;5.383;
1.1) Remuneration to researchers;677.784;221.447;225.782;228.981;1.573;
1.2) Remuneration to technicians and assistants;290.584;122.809;107.902;58.884;989;
1.3) Other current expenses;705.342;375.459;233.402;93.661;2.820;
2) By nature of the expense: Capital expenses;109.301;49.715;29.842;29.637;106;
2.1) Land and buildings;18.585;9.521;3.511;5.553;0;
2.2) Equipment and instruments;78.285;30.466;25.115;22.598;106;
2.3) Acquisition of specific R+D software;4.139;1.810;1.014;1.314;1;
2.4) Otros productos de propiedad intelectual específicos para I+D;8.292;7.919;202;172;0;
1.1) By origin of the funds: Own funds;639.755;490.913;69.873;78.383;585;
1.2) By origin of the funds: From companies;189.495;82.548;77.770;28.349;828;
1.3) By origin of the funds: Public Administration funds;737.076;96.809;379.076;258.952;2.239;
1.4) By origin of the funds: From Universities;2.962;197;1.380;1.309;75;
1.5) By origin of the funds: From non profit private institutions;24.088;4.766;11.426;6.679;1.217;
1.6) By origin of the funds: Foreign funds;189.635;94.197;57.401;37.492;545;
Purchase of services R & D in Biotechnology to (thousands of euros);153.607;120.281;26.850;6.101;375;
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;98.024;69.564;22.379;5.769;312;
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;55.583;50.718;4.470;332;63;
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;47;45;59;58;75;
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;12;12;3;12;25;
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;20;16;41;40;33;
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;16;14;28;36;25;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;19;16;33;43;33;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;20;18;30;40;25;
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;15;15;11;11;33;
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;37;37;42;34;42;
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;53;52;61;61;58;
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;20;20;20;19;25;
%Units that have requested biotechnology patents in Biotechnology;21;15;45;75;8;
Number of patents requested;1.785;681;555;548;1;
Notas:
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute